Frontiers in Neurology (Jun 2021)
Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas
- Mingze Wang,
- Mingze Wang,
- Mingze Wang,
- Mingze Wang,
- Yuming Jiao,
- Yuming Jiao,
- Yuming Jiao,
- Yuming Jiao,
- Chaofan Zeng,
- Chaofan Zeng,
- Chaofan Zeng,
- Chaofan Zeng,
- Chaoqi Zhang,
- Chaoqi Zhang,
- Chaoqi Zhang,
- Chaoqi Zhang,
- Qiheng He,
- Qiheng He,
- Qiheng He,
- Qiheng He,
- Yi Yang,
- Yi Yang,
- Yi Yang,
- Yi Yang,
- Wenjun Tu,
- Wenjun Tu,
- Wenjun Tu,
- Wenjun Tu,
- Hancheng Qiu,
- Hancheng Qiu,
- Hancheng Qiu,
- Hancheng Qiu,
- Huaizhang Shi,
- Dong Zhang,
- Dong Zhang,
- Dong Zhang,
- Dong Zhang,
- Dezhi Kang,
- Shuo Wang,
- Shuo Wang,
- Shuo Wang,
- Shuo Wang,
- A-li Liu,
- A-li Liu,
- A-li Liu,
- A-li Liu,
- A-li Liu,
- Weijian Jiang,
- Yong Cao,
- Yong Cao,
- Yong Cao,
- Yong Cao,
- Jizong Zhao,
- Jizong Zhao,
- Jizong Zhao,
- Jizong Zhao,
- Jizong Zhao
Affiliations
- Mingze Wang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Mingze Wang
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Mingze Wang
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Mingze Wang
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Yuming Jiao
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yuming Jiao
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Yuming Jiao
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Yuming Jiao
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Chaofan Zeng
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Chaofan Zeng
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Chaofan Zeng
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Chaofan Zeng
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Chaoqi Zhang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Chaoqi Zhang
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Chaoqi Zhang
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Chaoqi Zhang
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Qiheng He
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Qiheng He
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Qiheng He
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Qiheng He
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Yi Yang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yi Yang
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Yi Yang
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Yi Yang
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Wenjun Tu
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Wenjun Tu
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Wenjun Tu
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Wenjun Tu
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Hancheng Qiu
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Hancheng Qiu
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Hancheng Qiu
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Hancheng Qiu
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Huaizhang Shi
- Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
- Dong Zhang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Dong Zhang
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Dong Zhang
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Dong Zhang
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Dezhi Kang
- Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
- Shuo Wang
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Shuo Wang
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Shuo Wang
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Shuo Wang
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- A-li Liu
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- A-li Liu
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- A-li Liu
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- A-li Liu
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- A-li Liu
- Gamma Knife Center, Beijing Neurosurgical Institute, Beijing, China
- Weijian Jiang
- Department of Vascular Neurosurgery, Chinese People's Liberation Army Rocket Army Characteristic Medical Center, Beijing, China
- Yong Cao
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Yong Cao
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Yong Cao
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Yong Cao
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Jizong Zhao
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- Jizong Zhao
- China National Clinical Research Center for Neurological Diseases, Beijing, China
- Jizong Zhao
- Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- Jizong Zhao
- Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- Jizong Zhao
- Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China
- DOI
- https://doi.org/10.3389/fneur.2021.651663
- Journal volume & issue
-
Vol. 12
Abstract
Aim: The aim of this guideline is to present current and comprehensive recommendations for the management of brain arteriovenous malformations (bAVMs) located in eloquent areas.Methods: An extended literature search on MEDLINE was performed between Jan 1970 and May 2020. Eloquence-related literature was further screened and interpreted in different subcategories of this guideline. The writing group discussed narrative text and recommendations through group meetings and online video conferences. Recommendations followed the Applying Classification of Recommendations and Level of Evidence proposed by the American Heart Association/American Stroke Association. Prerelease review of the draft guideline was performed by four expert peer reviewers and by the members of Chinese Stroke Association.Results: In total, 809 out of 2,493 publications were identified to be related to eloquent structure or neurological functions of bAVMs. Three-hundred and forty-one publications were comprehensively interpreted and cited by this guideline. Evidence-based guidelines were presented for the clinical evaluation and treatment of bAVMs with eloquence involved. Topics focused on neuroanatomy of activated eloquent structure, functional neuroimaging, neurological assessment, indication, and recommendations of different therapeutic managements. Fifty-nine recommendations were summarized, including 20 in Class I, 30 in Class IIa, 9 in Class IIb, and 2 in Class III.Conclusions: The management of eloquent bAVMs remains challenging. With the evolutionary understanding of eloquent areas, the guideline highlights the assessment of eloquent bAVMs, and a strategy for decision-making in the management of eloquent bAVMs.
Keywords
